Brussels, 06/07/2001 (Agence Europe) - As we pointed out, the European Commission has adopted a decision enjoining IMS Health, the top German company in data collection on pharmaceutical product sales and prescriptions, to grant its competitors a licence allowing them to use its « structure made up of 1860 segments ». After detailed analysis, the European executive body considered that IMS's refusal to grant a licence for the use of its structure represented at first sight an abuse of a...